References
1. John S. Gibson and David C. Rees. How benign is sickle cell trait? EBioMedicine. 2016 Sep; 11: 21–22.
2. Voskaridou E, Christoulas D, Terpos E. Sickle-cell disease and the heart: Review of the current literature. Br J Haematol. 2012;157(6):664-673. doi: 10.1111/j.1365- 2141.2012.09143.x
3. Mennes I, Van de Velde M, Missant C. Sickle cell anaemia and the consequences on the anaesthetic management of cardiac surgery. Acta Anaesthesiol Belg 2012;63:81‑89.
4. Heiner M, Teasdale SJ, David T, Scott AA, Glynn MF. Aorta-coronary bypass in a patient with sickle cell trait. Can Anaesth Soc J. 1979;26: 428 – 434.
5. Djaiani GN, Cheng DC, Carroll JA, Yudin M, Karski JM. Fast-track cardiac anesthesia in patients with sickle cell abnormalities. Anesth Analg. 1999;89: 598 – 6038.
6. Howard J, Malfroy M, Llewelyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: A randomised, controlled, multicentre clinical trial. Lancet. 2013;381(9870):930-938. doi: 10.1016/S0140- 6736(12)61726-7.
7. Sachithanandan A, Nanjaiah P, Wright CJ, Rooney SJ. Mitral and tricuspid valve surgery in homozygous sickle cell disease: perioperative considerations for a successful outcome.J Card Surg. 2008;23:167–168.
8. Lazopoulos G, Kantartzis MM, Kantartzis M. Mitral valve replacement and tricuspid valve repair in a patient with sickle cell disease. Thorac Cardiovasc Surg 2008;56:567.
9. Sajjad M. Yousafzai, MD; Murat Ugurlucan, MD; Omar A. Al Radhwan, MD; Amal L. Al Otaibi, CP; Charles C. Canver, MD Open Heart Surgery in Patients with Sickle Cell Hemoglobinopathy (Circulation. 2010;121: 14-19.).
10. Stehlik J, Johnson SA, Selzman CH. Gold standard in anticoagulation assessment of left ventricular assist device patients? how about bronze. JACC. Heart failure. 2015; 3:323–326. [PubMed: 25770402].
11. Thein SL. Genetic association studies in β hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2013;2013:354‑61.
12. Ashley-Koch A, Yang Q, Olney R. Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol. 2000;151:839–45.
13.Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012;59(13):1123-1133. doi: 10.1016/j.jacc.2011.10.900.
14. Sachdev V, Machado RF, Shizukuda Y, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol. 2007;49(4):472-479. doi: S0735-1097(06)02776-8.
15.Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med. 2004;350(9):857-859. doi: 10.1056/NEJMp038250.
16. Payal Shah et al. Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls. Hematologica . Vol. 105 No. 1 (2020): January, 2020. https://doi.org/10.3324/haematol.2018.211391.
17. Khan SA, Damanhouri G, Ali A, Khan SA, Khan A, Bakillah A, Marouf S, Al Harbi G, Halawani SH, Makki A. Precipitating factors and targeted therapies in combating the perils of sickle cell disease— A special nutritional consideration. Nutr Metab (Lond). 2016 Aug 8; 13:50. doi: 10.1186/s12986-016-0109-7. PMID: 27508000; PMCID: PMC4977632.
18. Hemming AE. Pro: exchange transfusion is required for sickle cell trait patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004;18: 663 – 665.
19. Messent M. Con: exchange transfusion is not required for sickle cell trait patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004;18: 666 – 667.
20. Yousafzai SM, Ugurlucan M, Al Radhwan OA, Al Otaibi AL, Canver CC. Open heart surgery in patients with sickle cell hemoglobinopathy. Circulation 2010;121:14‑9.
21.France Pirenne and Karina Yazdanbakhsh. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions Blood The American Society of Hematology 2018Jun 2; 131 (25): 2773-2781.
22. Hulatt LJ, Fisher W. Intra-operative cell salvage and sickle cell carrier status. Anaesthesia 2010; 65: 646-56.
23. Stephen A. Esper and Jonathan H. Waters. Intra-operative cell salvage: a fresh look at the indications and contraindications Blood Transfus. 2011 Apr; 9(2): 139–147.
24. Eric A. Rose, M.D., Annetine C. Gelijns, Ph.D., Alan J. Moskowitz, M.D., Daniel F. Heitjan. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure NEJM 2001 (345) 1435-43.
25. Abozer Y. Elderderya, b, d, Abdulaziz S. Alshaibana, Reference Value Profile for Healthy Individuals from the Aljouf region of Saudi Arabia J Hematol. 2017;6(1):6-11.